Published in Subst Abuse Treat Prev Policy on October 05, 2012
Evaluation of district mental healthcare plans: the PRIME consortium methodology. Br J Psychiatry (2015) 1.10
Reliability and Validity of Alcohol Use Disorder dentification Test-Korean Revised Version for Screening At-risk Drinking and Alcohol Use Disorders. Korean J Fam Med (2014) 0.91
Maternal mental health in primary care in five low- and middle-income countries: a situational analysis. BMC Health Serv Res (2016) 0.79
Intra-household evaluations of alcohol abuse in men with depression and suicide in women: A cross-sectional community-based study in Chennai, India. BMC Public Health (2015) 0.79
Health and Socioeconomic Status of the Elderly People Living in Hilly Areas of Pakhribas, Kosi Zone, Nepal. Indian J Community Med (2016) 0.75
Treatment gap and barriers for mental health care: A cross-sectional community survey in Nepal. PLoS One (2017) 0.75
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction (1993) 41.55
Alcohol and public health. Lancet (2005) 10.82
Clinical practice. Unhealthy alcohol use. N Engl J Med (2005) 4.86
The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res (2007) 4.84
The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcohol Clin Exp Res (2002) 4.24
The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol (1995) 4.15
Screening for alcohol problems in primary care: a systematic review. Arch Intern Med (2000) 3.97
Patients with alcohol problems. N Engl J Med (1998) 3.84
A review of research on the Alcohol Use Disorders Identification Test (AUDIT). Alcohol Clin Exp Res (1997) 3.62
Validity of the alcohol use disorders identification test in college students. Alcohol Clin Exp Res (2004) 2.30
Audit-3 and audit-4: effectiveness of two short forms of the alcohol use disorders identification test. Alcohol Alcohol (2002) 1.67
Detection of patients with high alcohol intake by general practitioners. Br Med J (Clin Res Ed) (1986) 1.49
A comparison of parametric and nonparametric approaches to ROC analysis of quantitative diagnostic tests. Med Decis Making (1997) 1.49
Screening for alcohol use disorders and at-risk drinking in the general population: psychometric performance of three questionnaires. Alcohol Alcohol (2002) 1.48
The Alcohol Use Disorders Identification Test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version. Alcohol Clin Exp Res (2005) 1.31
Self-report screening tests for alcohol problems in primary care. Arch Intern Med (1995) 1.28
The Alcohol Use Disorders Identification Test (AUDIT) as a screen for at-risk drinking in primary care patients of different racial/ethnic backgrounds. Addiction (1997) 1.26
The alcohol use disorders identification test: an aid to recognition of alcohol problems in primary care patients. Prev Med (2001) 1.25
Reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) imbedded within a general health risk screening questionnaire: results of a survey in 332 primary care patients. Alcohol Clin Exp Res (2000) 1.23
Brief intervention in a primary care setting for hazardous drinkers. Am J Prev Med (1998) 1.17
The reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) in a German general practice population sample. J Stud Alcohol (2006) 1.15
An epidemiological survey of alcohol use disorders in a Tibetan population. Psychiatry Res (2008) 1.11
Screening for problem drinking: impact on physician behavior and patient drinking habits. J Gen Intern Med (1998) 1.09
Concurrent and construct validity of the audit in an urban brazilian sample. Alcohol Alcohol (2005) 1.04
Prevalence of alcohol dependence in a town in Nepal as assessed by the CAGE questionnaire. Addiction (2003) 0.97
Alcohol Use Disorders Identification Test (AUDIT): establishment of cut-off scores in a hospitalized Chinese population. Alcohol Clin Exp Res (2005) 0.95
Alcohol, Europe and the developing countries. Addiction (1997) 0.91
A comparison of the Alcohol Use Disorder Identification Test (AUDIT) in general population surveys in nine European countries. Alcohol Alcohol Suppl (2006) 0.90
[The "standard drink unit" as a simplified record of alcoholic drink consumption and its measurement in Spain]. Med Clin (Barc) (1999) 0.89
Prevalence of alcohol problems among emergency room patients in Thailand. Addiction (1998) 0.89
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol (2007) 7.36
Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis (2013) 4.03
Budd-Chiari syndrome: a review by an expert panel. J Hepatol (2003) 3.69
A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ (2006) 3.11
Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology (2010) 2.82
Snake bite in South Asia: a review. PLoS Negl Trop Dis (2010) 2.67
Impact of snake bites and determinants of fatal outcomes in southeastern Nepal. Am J Trop Med Hyg (2004) 2.42
Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med (2002) 2.40
EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol (2003) 2.37
Urbanisation and infectious diseases in a globalised world. Lancet Infect Dis (2011) 2.30
Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. BMJ (2010) 2.30
Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med (2009) 2.26
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res (2011) 2.21
Visceral leishmaniasis: elimination with existing interventions. Lancet Infect Dis (2011) 2.19
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology (2002) 2.06
Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C. J Hepatol (2005) 2.00
Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology (2013) 1.89
Early prediction of acute pancreatitis: prospective study comparing computed tomography scans, Ranson, Glascow, Acute Physiology and Chronic Health Evaluation II scores, and various serum markers. World J Surg (2002) 1.87
Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil". Am J Gastroenterol (2009) 1.83
Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis (2013) 1.82
Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal. Am J Trop Med Hyg (2010) 1.74
Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study. PLoS Negl Trop Dis (2011) 1.67
Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg Infect Dis (2009) 1.64
Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. PLoS Negl Trop Dis (2011) 1.64
Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? Trop Med Int Health (2008) 1.63
Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl Trop Dis (2010) 1.61
Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment. Trop Med Int Health (2008) 1.59
A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis (2012) 1.59
A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis. Am J Trop Med Hyg (2004) 1.57
Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes. Liver Int (2010) 1.57
Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology (2002) 1.57
NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness. PLoS Negl Trop Dis (2010) 1.55
Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol (2009) 1.52
Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol (2003) 1.51
Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal. PLoS Negl Trop Dis (2010) 1.50
Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent. Infect Genet Evol (2008) 1.49
Antigen genes for molecular epidemiology of leishmaniasis: polymorphism of cysteine proteinase B and surface metalloprotease glycoprotein 63 in the Leishmania donovani complex. J Infect Dis (2004) 1.49
Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda. Trop Med Int Health (2009) 1.48
Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors. Trop Med Int Health (2006) 1.43
Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis (2010) 1.42
Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. PLoS Negl Trop Dis (2011) 1.42
Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation. Int J Dermatol (2005) 1.42
Managing a wooden foreign body in the neck. J Emerg Trauma Shock (2009) 1.41
Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? Microbes Infect (2007) 1.40
Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC Infect Dis (2008) 1.39
Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal. Trop Med Int Health (2010) 1.36
The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine. Am J Trop Med Hyg (2005) 1.36
Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease. Cochrane Database Syst Rev (2014) 1.35
Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Negl Trop Dis (2010) 1.35
Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrob Agents Chemother (2005) 1.34
The epidemiology of Leishmania donovani infection in high transmission foci in India. Trop Med Int Health (2010) 1.30
Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral Leishmaniasis, by using human antibody responses to sand fly saliva. Am J Trop Med Hyg (2010) 1.30
Domestic animals and epidemiology of visceral leishmaniasis, Nepal. Emerg Infect Dis (2010) 1.29
Liposomal amphotericin B as a treatment for human leishmaniasis. Expert Opin Emerg Drugs (2012) 1.24
Tolerance and safety of nifurtimox in patients with chronic chagas disease. Clin Infect Dis (2010) 1.23
Metabolomics to unveil and understand phenotypic diversity between pathogen populations. PLoS Negl Trop Dis (2010) 1.21
Diagnostic accuracy of a new Leishmania PCR for clinical visceral leishmaniasis in Nepal and its role in diagnosis of disease. Trop Med Int Health (2008) 1.21
A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med (2007) 1.21
Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol (2005) 1.17
Epidemiological dynamics of antimonial resistance in Leishmania donovani: genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal. Infect Genet Evol (2006) 1.17
Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India. Clin Vaccine Immunol (2010) 1.16
PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar. Trop Med Int Health (2009) 1.16
Phlebotomus argentipes seasonal patterns in India and Nepal. J Med Entomol (2010) 1.14
An unusual case of gastric heterotopic pancreas. JOP (2004) 1.13
Prevalence of coronary heart disease in the urban adult males of eastern Nepal: a population-based analytical cross-sectional study. Indian Heart J (2010) 1.13
Population preference of net texture prior to bed net trial in Kala-Azar-endemic areas. PLoS Negl Trop Dis (2007) 1.13
Linking in vitro and in vivo survival of clinical Leishmania donovani strains. PLoS One (2010) 1.12
Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background. PLoS Negl Trop Dis (2012) 1.11
Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests. BMC Infect Dis (2013) 1.11
Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J Hepatol (2002) 1.11
Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo. Clin Infect Dis (2012) 1.11
Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology (2008) 1.10
Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes. Trans R Soc Trop Med Hyg (2008) 1.09
Accuracy of five algorithms to diagnose gambiense human African trypanosomiasis. PLoS Negl Trop Dis (2011) 1.09
Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial. PLoS Negl Trop Dis (2011) 1.08
Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro. Mol Cancer (2006) 1.07
Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal. Trop Med Int Health (2006) 1.04
Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs. BMC Public Health (2012) 1.04
Severe acute pancreatitis and reduced acinar cell apoptosis in the exocrine pancreas of mice deficient for the Cx32 gene. Gastroenterology (2003) 1.04
Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study. J Hepatol (2009) 1.03
Residual activity and integrity of PermaNet® 2.0 after 24 months of household use in a community randomised trial of long lasting insecticidal nets against visceral leishmaniasis in India and Nepal. Trans R Soc Trop Med Hyg (2011) 1.03
Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo. Confl Health (2011) 1.03
Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden. PLoS One (2011) 1.03
Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children. Acta Trop (2006) 1.03
Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA. Trop Med Int Health (2010) 1.02
Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis. J Hepatol (2004) 1.02
Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL). Trop Med Int Health (2006) 1.02
Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010). PLoS Negl Trop Dis (2011) 1.01
Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One (2013) 0.99
Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol. PLoS Negl Trop Dis (2012) 0.98
Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex. Infect Genet Evol (2011) 0.98